HGNC Family | Regulators of G-protein signaling (RGS), Endogenous ligands |
Name | regulator of G-protein signaling 2 |
Description | Regulator of G protein signaling (RGS) family members are regulatory molecules that act as GTPase activating proteins (GAPs) for G alpha subunits of heterotrimeric G proteins. RGS proteins are able to deactivate G protein subunits of the Gi alpha, Go alpha and Gq alpha subtypes. They drive G proteins into their inactive GDP-bound forms. Regulator of G protein signaling 2 belongs to this family. The protein acts as a mediator of myeloid differentiation and may play a role in leukemogenesis. [provided by RefSeq, Aug 2009] |
Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRGS2 is emerging as a critical modulator of G‐protein–coupled receptor signaling with a central role in cardiovascular and respiratory physiology. Acting as a GTPase‐activating protein (GAP), RGS2 preferentially attenuates Gαq‐mediated pathways, thereby fine‐tuning vasoconstrictor responses, regulating adenylyl cyclase activity and ultimately contributing to blood pressure homeostasis. In vascular smooth muscle, reduced RGS2 expression or mutations that enhance its degradation via N‐end rule pathways have been linked to hypertension and preeclamptic phenotypes, while in airway smooth muscle RGS2 induction by combination glucocorticoid/long‐acting β₂‐agonist treatments mediates bronchoprotection by dampening Ca²⁺ mobilization in response to contractile stimuli."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "11"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its vascular actions, RGS2 plays a significant role in neural signaling and behavioral regulation. Variations in the RGS2 gene and altered expression levels have been associated with anxiety disorders, panic and posttraumatic stress disorder, as well as with adverse motor side‐effects from antipsychotic drugs. By modulating receptor–effector coupling in dopaminergic and adrenergic systems, RGS2 contributes to the fine tuning of neuronal responsiveness that underlies stress‐related and affective phenotypes."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "12", "end_ref": "23"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the context of cancer biology, RGS2 appears to function as a tumor suppressor. Numerous studies have reported that downregulation—often through epigenetic mechanisms—of RGS2 is common in breast, colorectal, ovarian, and bladder cancers. Loss of RGS2 expression correlates with enhanced growth, increased transformation potential, and poorer clinical outcome, while restoration of its expression suppresses oncogenic signaling and proliferation. Such findings have raised the prospect of RGS2 serving as both a prognostic biomarker and a target for therapeutic intervention in malignancies."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "24", "end_ref": "32"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAt the molecular level, RGS2 integrates diverse signal transduction pathways through direct protein–protein interactions and post‐translational modifications. It directly associates with specific GPCRs and scaffolding partners (such as spinophilin), modulates adenylyl cyclase and Ca²⁺ channel activity, and is itself subject to precise regulation by processes including N‑terminal acetylation and proteasomal degradation. Epigenetic modifications further control RGS2 expression, linking its dysregulation not only to altered receptor signaling in cellular homeostasis but also to cognitive deficits observed in neurodegenerative diseases. Collectively, these multifaceted interactions underscore the role of RGS2 as a pivotal hub orchestrating the cellular response to extracellular stimuli."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "33", "end_ref": "41"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Samina Salim, Srikumar Sinnarajah, John H Kehrl, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of RGS2 and type V adenylyl cyclase interaction sites."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M210663200"}], "href": "https://doi.org/10.1074/jbc.M210663200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12604604"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12604604"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Lorenzo A Calò, Elisa Pagnin, Paul A Davis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter's/Gitelman's syndrome. A role in the control of vascular tone and implication for hypertension."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2004-0498"}], "href": "https://doi.org/10.1210/jc.2004-0498"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15292363"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15292363"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Jin Yang, Kei Kamide, Yoshihiro Kokubo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic variations of regulator of G-protein signaling 2 in hypertensive patients and in the general population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hypertens (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/01.hjh.0000174606.41651.ae"}], "href": "https://doi.org/10.1097/01.hjh.0000174606.41651.ae"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16003176"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16003176"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Andrea Semplicini, Livia Lenzini, Michelangelo Sartori, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reduced expression of regulator of G-protein signaling 2 (RGS2) in hypertensive patients increases calcium mobilization and ERK1/2 phosphorylation induced by angiotensin II."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hypertens (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/01.hjh.0000226202.80689.8f"}], "href": "https://doi.org/10.1097/01.hjh.0000226202.80689.8f"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16685212"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16685212"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Neil S Holden, Matthew J Bell, Christopher F Rider, et al. "}, {"type": "b", "children": [{"type": "t", "text": "β2-Adrenoceptor agonist-induced RGS2 expression is a genomic mechanism of bronchoprotection that is enhanced by glucocorticoids."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1110226108"}], "href": "https://doi.org/10.1073/pnas.1110226108"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22080612"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22080612"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Yan Xie, Haihong Jiang, Hoai Nguyen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulator of G protein signaling 2 is a key modulator of airway hyperresponsiveness."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Allergy Clin Immunol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jaci.2012.05.004"}], "href": "https://doi.org/10.1016/j.jaci.2012.05.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22704538"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22704538"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Katsuhiko Kohara, Yasuharu Tabara, Jun Nakura, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of hypertension-susceptibility genes and pathways by a systemic multiple candidate gene approach: the millennium genome project for hypertension."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hypertens Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1291/hypres.31.203"}], "href": "https://doi.org/10.1291/hypres.31.203"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18360038"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18360038"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Anne Stine Kvehaugen, Oyvind Melien, Oddgeir Lingaas Holmen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Single nucleotide polymorphisms in G protein signaling pathway genes in preeclampsia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hypertension (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/HYPERTENSIONAHA.111.00331"}], "href": "https://doi.org/10.1161/HYPERTENSIONAHA.111.00331"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23339167"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23339167"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Nan Sethakorn, Nickolai O Dulin "}, {"type": "b", "children": [{"type": "t", "text": "RGS expression in cancer: oncomining the cancer microarray data."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Recept Signal Transduct Res (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3109/10799893.2013.773450"}], "href": "https://doi.org/10.3109/10799893.2013.773450"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23464602"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23464602"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Yin Ruixing, Wu Jinzhen, Lin Weixiong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The environmental and genetic evidence for the association of hyperlipidemia and hypertension."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hypertens (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/HJH.0b013e32831bc74d"}], "href": "https://doi.org/10.1097/HJH.0b013e32831bc74d"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19155782"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19155782"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Yan Xie, Haihong Jiang, Qian Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Upregulation of RGS2: a new mechanism for pirfenidone amelioration of pulmonary fibrosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Respir Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12931-016-0418-4"}], "href": "https://doi.org/10.1186/s12931-016-0418-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27549302"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27549302"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Jordan W Smoller, Martin P Paulus, Jesen A Fagerness, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Influence of RGS2 on anxiety-related temperament, personality, and brain function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Gen Psychiatry (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1001/archgenpsychiatry.2007.48"}], "href": "https://doi.org/10.1001/archgenpsychiatry.2007.48"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18316676"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18316676"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Chris Hague, Leah S Bernstein, Suneela Ramineni, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Selective inhibition of alpha1A-adrenergic receptor signaling by RGS2 association with the receptor third intracellular loop."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M502365200"}], "href": "https://doi.org/10.1074/jbc.M502365200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15917235"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15917235"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "A Leygraf, C Hohoff, C Freitag, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Rgs 2 gene polymorphisms as modulators of anxiety in humans?"}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neural Transm (Vienna) (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00702-006-0484-8"}], "href": "https://doi.org/10.1007/s00702-006-0484-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16736243"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16736243"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Ananda B Amstadter, Karestan C Koenen, Kenneth J Ruggiero, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Variant in RGS2 moderates posttraumatic stress symptoms following potentially traumatic event exposure."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Anxiety Disord (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.janxdis.2008.12.005"}], "href": "https://doi.org/10.1016/j.janxdis.2008.12.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19162436"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19162436"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "L J Strug, R Suresh, A J Fyer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Panic disorder is associated with the serotonin transporter gene (SLC6A4) but not the promoter region (5-HTTLPR)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Psychiatry (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/mp.2008.79"}], "href": "https://doi.org/10.1038/mp.2008.79"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18663369"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18663369"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Adam J Kimple, Meera Soundararajan, Stephanie Q Hutsell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structural determinants of G-protein alpha subunit selectivity by regulator of G-protein signaling 2 (RGS2)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M109.024711"}], "href": "https://doi.org/10.1074/jbc.M109.024711"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19478087"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19478087"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Mélanie Hamel, Isabelle Dufort, Claude Robert, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genomic assessment of follicular marker genes as pregnancy predictors for human IVF."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Hum Reprod (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/molehr/gap079"}], "href": "https://doi.org/10.1093/molehr/gap079"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19778949"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19778949"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Evan L Riddle, Brinda K Rana, Kenton K Murthy, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Polymorphisms and haplotypes of the regulator of G protein signaling-2 gene in normotensives and hypertensives."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hypertension (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/01.HYP.0000200714.81990.61"}], "href": "https://doi.org/10.1161/01.HYP.0000200714.81990.61"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16432041"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16432041"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Karestan C Koenen, Ananda B Amstadter, Kenneth J Ruggiero, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RGS2 and generalized anxiety disorder in an epidemiologic sample of hurricane-exposed adults."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Depress Anxiety (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/da.20528"}], "href": "https://doi.org/10.1002/da.20528"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18833580"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18833580"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Huxing Cui, Naoki Nishiguchi, Elena Ivleva, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of RGS2 gene polymorphisms with suicide and increased RGS2 immunoreactivity in the postmortem brain of suicide victims."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropsychopharmacology (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.npp.1301557"}], "href": "https://doi.org/10.1038/sj.npp.1301557"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17728697"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17728697"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Lior Greenbaum, Rael D Strous, Kyra Kanyas, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of the RGS2 gene with extrapyramidal symptoms induced by treatment with antipsychotic medication."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenet Genomics (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/FPC.0b013e32800ffbb4"}], "href": "https://doi.org/10.1097/FPC.0b013e32800ffbb4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17558307"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17558307"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "L Greenbaum, R C Smith, A Rigbi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Further evidence for association of the RGS2 gene with antipsychotic-induced parkinsonism: protective role of a functional polymorphism in the 3'-untranslated region."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenomics J (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/tpj.2008.6"}], "href": "https://doi.org/10.1038/tpj.2008.6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18347610"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18347610"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "X Cao, J Qin, Y Xie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulator of G-protein signaling 2 (RGS2) inhibits androgen-independent activation of androgen receptor in prostate cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.onc.1209408"}], "href": "https://doi.org/10.1038/sj.onc.1209408"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16449965"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16449965"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Joachim Schwäble, Chunaram Choudhary, Christian Thiede, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RGS2 is an important target gene of Flt3-ITD mutations in AML and functions in myeloid differentiation and leukemic transformation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2004-03-0940"}], "href": "https://doi.org/10.1182/blood-2004-03-0940"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15536149"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15536149"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "David M Berman, Yunfei Wang, Zhengyu Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A functional polymorphism in RGS6 modulates the risk of bladder cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-04-1916"}], "href": "https://doi.org/10.1158/0008-5472.CAN-04-1916"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15375002"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15375002"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Ji Hyo Lyu, Dae-Weon Park, Bin Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RGS2 suppresses breast cancer cell growth via a MCPIP1-dependent pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.24964"}], "href": "https://doi.org/10.1002/jcb.24964"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25187114"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25187114"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Ercan Cacan "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetic regulation of RGS2 (Regulator of G-protein signaling 2) in chemoresistant ovarian cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Chemother (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/1120009X.2016.1277007"}], "href": "https://doi.org/10.1080/1120009X.2016.1277007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28102109"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28102109"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Liang Ying, Jun Lin, Feng Qiu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetic repression of regulator of G-protein signaling 2 by ubiquitin-like with PHD and ring-finger domain 1 promotes bladder cancer progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS J (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/febs.13116"}], "href": "https://doi.org/10.1111/febs.13116"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25323766"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25323766"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Zheng Jiang, Zhimin Wang, Ye Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biosci Rep (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BSR20090129"}], "href": "https://doi.org/10.1042/BSR20090129"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20001967"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20001967"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Jaebeom Cho, Hye-Young Min, Ho Jin Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RGS2-mediated translational control mediates cancer cell dormancy and tumor relapse."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI136779"}], "href": "https://doi.org/10.1172/JCI136779"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33393490"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33393490"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Stephen C Tovey, Gary B Willars "}, {"type": "b", "children": [{"type": "t", "text": "Single-cell imaging of intracellular Ca2+ and phospholipase C activity reveals that RGS 2, 3, and 4 differentially regulate signaling via the Galphaq/11-linked muscarinic M3 receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Pharmacol (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/mol.104.005827"}], "href": "https://doi.org/10.1124/mol.104.005827"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15383626"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15383626"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Ana Jovicic, Julien Francisco Zaldivar Jolissaint, Roger Moser, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington's disease-related mechanisms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0054222"}], "href": "https://doi.org/10.1371/journal.pone.0054222"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23349832"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23349832"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Sang-Eun Park, Jeong-Mok Kim, Ok-Hee Seok, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Control of mammalian G protein signaling by N-terminal acetylation and the N-end rule pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.aaa3844"}], "href": "https://doi.org/10.1126/science.aaa3844"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25766235"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25766235"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Xinhua Wang, Weizhong Zeng, Abigail A Soyombo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Spinophilin regulates Ca2+ signalling by binding the N-terminal domain of RGS2 and the third intracellular loop of G-protein-coupled receptors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Cell Biol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncb1237"}], "href": "https://doi.org/10.1038/ncb1237"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15793568"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15793568"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Johannes Bodenstein, Roger K Sunahara, Richard R Neubig "}, {"type": "b", "children": [{"type": "t", "text": "N-terminal residues control proteasomal degradation of RGS2, RGS4, and RGS5 in human embryonic kidney 293 cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Pharmacol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/mol.106.029397"}], "href": "https://doi.org/10.1124/mol.106.029397"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17220356"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17220356"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Marie-Christine Nlend, Richard J Bookman, Gregory E Conner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulator of G-protein signaling protein 2 modulates purinergic calcium and ciliary beat frequency responses in airway epithelia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Respir Cell Mol Biol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1165/rcmb.2002-0012OC"}], "href": "https://doi.org/10.1165/rcmb.2002-0012OC"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12356577"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12356577"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Scott P Heximer, Kendall J Blumer "}, {"type": "b", "children": [{"type": "t", "text": "RGS proteins: Swiss army knives in seven-transmembrane domain receptor signaling networks."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci STKE (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/stke.3702007pe2"}], "href": "https://doi.org/10.1126/stke.3702007pe2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17244887"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17244887"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Lorenzo A Calò, Elisa Pagnin, Giulio Ceolotto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Silencing regulator of G protein signaling-2 (RGS-2) increases angiotensin II signaling: insights into hypertension from findings in Bartter's/Gitelman's syndromes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hypertens (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/HJH.0b013e3282f60d98"}], "href": "https://doi.org/10.1097/HJH.0b013e3282f60d98"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18398336"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18398336"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "A Hadar, E Milanesi, A Squassina, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RGS2 expression predicts amyloid-β sensitivity, MCI and Alzheimer's disease: genome-wide transcriptomic profiling and bioinformatics data mining."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Transl Psychiatry (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/tp.2016.179"}], "href": "https://doi.org/10.1038/tp.2016.179"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27701409"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27701409"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Damian G Romero, Maria W Plonczynski, Elise P Gomez-Sanchez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RGS2 is regulated by angiotensin II and functions as a negative feedback of aldosterone production in H295R human adrenocortical cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2005-1532"}], "href": "https://doi.org/10.1210/en.2005-1532"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16627589"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16627589"}]}]}]}
|
Synonyms | G0S8 |
Proteins | RGS2_HUMAN |
NCBI Gene ID | 5997 |
API | |
Download Associations | |
Predicted Functions |
![]() |
Co-expressed Genes |
![]() |
Expression in Tissues and Cell Lines |
![]() |
RGS2 has 15,353 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 112 datasets.
Click the + buttons to view associations for RGS2 from the datasets below.
If available, associations are ranked by standardized value
Dataset | Summary | |
---|---|---|
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of RGS2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of RGS2 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of RGS2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of RGS2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of RGS2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of RGS2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of RGS2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of RGS2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of RGS2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of RGS2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
CellMarker Gene-Cell Type Associations | cell types associated with RGS2 gene from the CellMarker Gene-Cell Type Associations dataset. | |
ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of RGS2 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
ChEA Transcription Factor Targets | transcription factors binding the promoter of RGS2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of RGS2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of RGS2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing RGS2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing RGS2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with RGS2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with RGS2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of RGS2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
COSMIC Cell Line Gene Mutation Profiles | cell lines with RGS2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
CTD Gene-Chemical Interactions | chemicals interacting with RGS2 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
CTD Gene-Disease Associations | diseases associated with RGS2 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
DepMap CRISPR Gene Dependency | cell lines with fitness changed by RGS2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
DISEASES Experimental Gene-Disease Association Evidence Scores | diseases associated with RGS2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset. | |
DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with RGS2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with RGS2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
DisGeNET Gene-Disease Associations | diseases associated with RGS2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
DisGeNET Gene-Phenotype Associations | phenotypes associated with RGS2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at RGS2 gene from the ENCODE Histone Modification Site Profiles dataset. | |
ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of RGS2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
ENCODE Transcription Factor Targets | transcription factors binding the promoter of RGS2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing RGS2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
GAD Gene-Disease Associations | diseases associated with RGS2 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
GAD High Level Gene-Disease Associations | diseases associated with RGS2 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of RGS2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
GeneRIF Biological Term Annotations | biological terms co-occuring with RGS2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing RGS2 from the GeneSigDB Published Gene Signatures dataset. | |
GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of RGS2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of RGS2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of RGS2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of RGS2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of RGS2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of RGS2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
GO Biological Process Annotations 2015 | biological processes involving RGS2 gene from the curated GO Biological Process Annotations 2015 dataset. | |
GO Biological Process Annotations 2023 | biological processes involving RGS2 gene from the curated GO Biological Process Annotations 2023 dataset. | |
GO Biological Process Annotations 2025 | biological processes involving RGS2 gene from the curated GO Biological Process Annotations2025 dataset. | |
GO Cellular Component Annotations 2015 | cellular components containing RGS2 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
GO Cellular Component Annotations 2023 | cellular components containing RGS2 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
GO Cellular Component Annotations 2025 | cellular components containing RGS2 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
GO Molecular Function Annotations 2015 | molecular functions performed by RGS2 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
GO Molecular Function Annotations 2023 | molecular functions performed by RGS2 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
GO Molecular Function Annotations 2025 | molecular functions performed by RGS2 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
GTEx eQTL 2025 | SNPs regulating expression of RGS2 gene from the GTEx eQTL 2025 dataset. | |
GTEx Tissue Gene Expression Profiles | tissues with high or low expression of RGS2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of RGS2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of RGS2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of RGS2 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of RGS2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of RGS2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
HPA Tissue Gene Expression Profiles | tissues with high or low expression of RGS2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of RGS2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
Hub Proteins Protein-Protein Interactions | interacting hub proteins for RGS2 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
HuBMAP Azimuth Cell Type Annotations | cell types associated with RGS2 gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
HuGE Navigator Gene-Phenotype Associations | phenotypes associated with RGS2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by RGS2 gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
InterPro Predicted Protein Domain Annotations | protein domains predicted for RGS2 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of RGS2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
KEA Substrates of Kinases | kinases that phosphorylate RGS2 protein from the curated KEA Substrates of Kinases dataset. | |
Kinase Library Serine Threonine Kinome Atlas | kinases that phosphorylate RGS2 protein from the Kinase Library Serine Threonine Atlas dataset. | |
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of RGS2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of RGS2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with RGS2 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of RGS2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of RGS2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of RGS2 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of RGS2 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain RGS2 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by RGS2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
MiRTarBase microRNA Targets | microRNAs targeting RGS2 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of RGS2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of RGS2 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by RGS2 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
MSigDB Cancer Gene Co-expression Modules | co-expressed genes for RGS2 from the MSigDB Cancer Gene Co-expression Modules dataset. | |
MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of RGS2 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of RGS2 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
PANTHER Pathways | pathways involving RGS2 protein from the PANTHER Pathways dataset. | |
Pathway Commons Protein-Protein Interactions | interacting proteins for RGS2 from the Pathway Commons Protein-Protein Interactions dataset. | |
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of RGS2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of RGS2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
PFOCR Pathway Figure Associations 2023 | pathways involving RGS2 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
PFOCR Pathway Figure Associations 2024 | pathways involving RGS2 protein from the Wikipathways PFOCR 2024 dataset. | |
Phosphosite Textmining Biological Term Annotations | biological terms co-occuring with RGS2 protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset. | |
PhosphoSitePlus Substrates of Kinases | kinases that phosphorylate RGS2 protein from the curated PhosphoSitePlus Substrates of Kinases dataset. | |
Reactome Pathways 2014 | pathways involving RGS2 protein from the Reactome Pathways dataset. | |
Reactome Pathways 2024 | pathways involving RGS2 protein from the Reactome Pathways 2024 dataset. | |
Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of RGS2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at RGS2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of RGS2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of RGS2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of RGS2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of RGS2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of RGS2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of RGS2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of RGS2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of RGS2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of RGS2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of RGS2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with RGS2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with RGS2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
WikiPathways Pathways 2014 | pathways involving RGS2 protein from the Wikipathways Pathways 2014 dataset. | |
WikiPathways Pathways 2024 | pathways involving RGS2 protein from the WikiPathways Pathways 2024 dataset. | |